spine_edited.jpg

SMART DEVICE FOR EPIDURAL INJECTIONS

OMEQ Medical Smart Device for Epidural Injections

 

EPIFINDER

Accurately Identifies the Epidural Space

MEASURES TISSUE RESISTANCE AT THE NEEDLE TIP

ENABLES INDEPENDENT OBJECTIVE SIGNAL TO CONFIRM CORRECT NEEDLE PLACEMENT

epifinder_edited.jpg
 
1.png

Integrates with standard kit and works simultaneously with LOR technique

2.png

Independent signal ensures correct placement

3.png

Reduces needle overshoot and incidence of PDH

4.png

Increases success in first attempt

5.png

Easy to operate

6.png

Reduces complication rate - Potential annual                 save of up to $0.5B
(US only)

 

WHY WE DEVELOPED THE EPIFINDER

 

The current technique to administer epidurals, loss of resistance (“LOR”), is a subjective technique: 


•Needle placement is based on tactile feedback and feel

•The technique requires extensive expertise

•Success is operator dependent

Omeq Medical Investor Deck June 21 - Copy - Copy.jpg
 
world.png

A ONE BILLION MARKET SIZE

40M Epidural injections annually

9.3% Compound annual growth rate

$20-$50 Epidural Kit price

 

MEET OUR TEAM

lior_edited.jpg
maya.jpg
jonathan.jpg
CarlR 2--3.jpg

Lior Margalit

CEO

Maya Shick

Clinical Director

Jonathan Harari
QA Consultant

Carl Rickenbaugh

Chairman 

 

CONTACT

4 Bezalel Street
Regev Capital Building, Ramat Gan 5252104 • Israel

+972-54-431-5304

  • LinkedIn
shai-pal-LJzggyttyMQ-unsplash.jpg